+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orthopedic Biomaterials Market Report Suite - China - 2020-2026 - Medsuite

  • PDF Icon

    Report

  • March 2020
  • Region: China
  • iData Research
  • ID: 5019855
Throughout this medical market research, the publisher analyzed 28 orthobiologics companies in China and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the China Orthopedic Biomaterials market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an orthobiologics procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered
  • Procedure Volumes for the China Orthopedic Biomaterials Devices – MedPro
  • Orthopedic Bone Graft Substitute Market - MedCore
  • Orthopedic Growth Factor Market - MedCore
  • Hyaluronic Acid Viscosupplementation Market - MedCore

China Orthopedic Biomaterials Market Insights

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 12% of the Chinese population was aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.

In the past, lower tier hospitals (I and II) were primarily served by local manufacturers with relatively simple products at significantly lower prices than the products purchased by tier III hospitals, which were primarily supplied by international companies. Now, with the financial and regulatory support of the government, increasingly difficult entry barriers for international products and weak intellectual property protection that incentivizes product plagiarism, the market has shifted in favor of local manufacturers.

Overall, the China orthopedic biomaterials market was valued at $460.7 million in 2019. This is expected to increase over the forecast period at a CAGR of 6% to reach $690.8 million.

Table of Contents

LIST OF FIGURESLIST OF CHARTS
EXECUTIVE SUMMARY
1.1 CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
1.2 COMPETITIVE ANALYSIS
1.3 MARKET TRENDS
1.4 KEY MARKET DEVELOPMENTS
1.5 PROCEDURE NUMBERS
1.6 MARKETS INCLUDED
1.7 KEY REPORT UPDATES
1.8 VERSION HISTORY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 Bone Graft Substitutes
3.1.2 Hyaluronic Acid Viscosupplementation
3.1.3 Growth Factors
3.2 CURRENCY EXCHANGE RATES
3.3 MARKET OVERVIEW
3.4 TREND ANALYSIS
3.5 DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
3.7 MERGERS AND ACQUISITIONS
PROCEDURE NUMBERS
4.1 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
4.1.1 Bone Graft Substitute Procedure Numbers by Material
4.1.2 Bone Graft Substitute Procedure Numbers by Indication
4.1.2.1 Bone Graft Substitute Units per Procedure by Indication
4.2 HYALURONIC ACID VISCOSUPPLEMENTATION PROCEDURE NUMBERS
4.2.1 Hyaluronic Acid Viscosupplementation Procedure Numbers by Injection Cycle
4.3 ORTHOPEDIC GROWTH FACTOR PROCEDURE NUMBERS
4.3.1 Orthopedic Growth Factor Procedure Numbers
BONE GRAFT SUBSTITUTE MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.2.1 Bone Graft Substitute Market by Material
5.2.2 Bone Graft Substitute Market by Indication
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Bone Graft Substitute Market
5.3.2 Total Bone Graft Substitute Market by Material
5.3.2.1 Allograft Bone Graft Substitute Market
5.3.2.2 Demineralized Bone Matrix Market
5.3.2.3 Synthetic Bone Graft Substitute Market
5.3.3 Total Bone Graft Substitute Market by Indication
5.3.3.1 Total Spine Market
5.3.3.1.1 Cervical Spine Market
5.3.3.1.2 Thoracolumbar Spine Market
5.3.3.2 Trauma & Reconstruction Market
5.3.3.3 Bone Tumor Market
5.3.3.4 CMF Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.2.1 Hyaluronic Acid Viscosupplementation Market by Injection Cycle
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Total Hyaluronic Acid Viscosupplementation Market
6.3.2 Total Hyaluronic Acid Viscosupplementation Market by Injection Cycle
6.3.2.1 Single-Injection Hyaluronic Acid Viscosupplementation Market
6.3.2.2 Three-Injection Hyaluronic Acid Viscosupplementation Market
6.3.2.3 Five-Injection Hyaluronic Acid Viscosupplementation Market
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS
ORTHOPEDIC GROWTH FACTOR MARKET
7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.2.1 Orthopedic Growth Factor Market
7.3 DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS
APPENDIX: LOCAL COMPETITOR DIRECTORY
8.1 WEBSITE DIRECTORY
ABBREVIATIONS

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allgens Medical
  • Biocomposites
  • Biolu Biomaterials
  • Bloomage Freda Biopharm
  • Datsing Bio-tech
  • DePuy Synthes
  • FocusChem
  • Genzyme
  • Guona Keji
  • Haghzhou Gallop
  • Harbin Gloria Pharmaceutical
  • Jinxingda Company (Tianjin)
  • Kunming Baker Norton
  • Medtronic
  • Novabone
  • Osteolink Biomaterials (Lianjie Company)
  • Seikagaku
  • Shanghai Anjiu Biotechnology
  • Shanghai HaoHai
  • Shanghai Jingfeng Pharmaceutical
  • Shanghai Rebone Biomaterials
  • Shanxi OsteoRad Biomaterials
  • Wright Medical
  • Xin Kang Chen
  • Yunkanghengye Company